Literature DB >> 11684575

Is "Chinese herbs nephropathy" a prejudicial term?

K Solez, J Daugirdas, M C Gregory, P P Frohnert, D M Bhowmik, V Jha, J P Cosyns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11684575     DOI： 10.1053/ajkd.2001.29661

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

Review 1.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Establishment and Validation of an In Vitro Screening Method for Traditional Chinese Medicine-Induced Nephrotoxicity.

Authors:  Zhe Ma; Xuexiao Cao; Xiao Guo; Meng Wang; Xiaoliang Ren; Ranran Dong; Rui Shao; Yan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-28       Impact factor: 2.629

3.  Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.

Authors:  Wen-Yeh Hsieh; Teng-Hsiang Chang; Hui-Fang Chang; Wan-Hsuan Chuang; Li-Che Lu; Chung-Wei Yang; Chih-Sheng Lin; Chia-Chu Chang
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

4.  QuEChERS pretreatment combined with high-performance liquid chromatography-tandem mass spectrometry for determination of aristolochic acids I and II in Chinese herbal patent medicines.

Authors:  Jinghe Zhang; Yinan Wang; Jing Sun; Guowei Zhou; Xiaojie Jiang; Xikui Wang
Journal:  RSC Adv       Date:  2020-07-03       Impact factor: 4.036

5.  A brief study of toxic effects of some medicinal herbs on kidney.

Authors:  Mohammad Asif
Journal:  Adv Biomed Res       Date:  2012-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.